Title	Publication Date	Language	Citations
Intestinal microbiota is altered in patients with colon cancer and modified by probiotic intervention	2017/07/01	English	206
Alteration in the gastric microbiota and its restoration by probiotics in patients with functional dyspepsia	2017/05/01	English	89
Cachexia in cancer: what is in the definition?	2016/10/01	English	83
Efficacy of dietary and physical activity intervention in non-alcoholic fatty liver disease: a systematic review	2017/06/01	English	82
Mechanisms of liver disease in patients infected with HIV	2017/10/01	English	80
High potency multistrain probiotic improves liver histology in non-alcoholic fatty liver disease (NAFLD): a randomised, double-blind, proof of concept study	2019/08/01	English	79
Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver disease	2016/03/01	English	78
Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts	2017/04/01	English	68
Novelty in the gut: a systematic review and meta-analysis of the gastrointestinal manifestations of COVID-19	2020/05/01	English	65
Impact of introducing a faecal immunochemical test (FIT) for haemoglobin into primary care on the outcome of patients with new bowel symptoms: a prospective cohort study	2019/05/01	English	62
Iron deficiency anaemia: pathophysiology, assessment, practical management	2022/01/01	English	62
Consensus for the management of pancreatic exocrine insufficiency: UK practical guidelines	2021/06/01	English	58
Gut microbiota associated with HIV infection is significantly enriched in bacteria tolerant to oxygen	2016/07/01	English	55
Assessment of health utilities and quality of life in patients with non-alcoholic fatty liver disease	2016/08/01	English	55
Hepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targets	2016/05/01	English	49
How bad is bile acid diarrhoea: an online survey of patient-reported symptoms and outcomes	2017/01/01	English	49
Gastric microbiota in the functional dyspepsia patients treated with probiotic yogurt	2016/09/01	English	49
Faecal microbiota transplantation: applications and limitations in treating gastrointestinal disorders	2016/05/01	English	48
Gastrointestinal mucosal damage in patients with COVID-19 undergoing endoscopy: an international multicentre study	2021/02/01	English	47
Gastroenterological and hepatic manifestations of patients with COVID-19, prevalence, mortality by country, and intensive care admission rate: systematic review and meta-analysis	2021/03/01	English	44
Changes in the gut microbiota composition and the plasma ghrelin level in patients withHelicobacter pylori-infected patients with eradication therapy	2017/11/01	English	43
Combination therapy with vedolizumab and etanercept in a patient with pouchitis and spondylarthritis	2017/02/01	English	42
Growth patterns of colorectal cancer liver metastases and their impact on prognosis: a systematic review	2018/07/01	English	42
Effectiveness of screening for colorectal cancer with a faecal occult-blood test, in Finland	2015/12/31	English	41
Risk factors for colorectal cancer significantly vary by anatomic site	2019/08/01	English	40
Panenteric capsule endoscopy versus ileocolonoscopy plus magnetic resonance enterography in Crohn’s disease: a multicentre, prospective study	2020/06/01	English	40
Gallstone ileus: a review	2019/11/01	English	39
Reliability and validity of the Chronic Liver Disease Questionnaire (CLDQ) in adults with non-alcoholic steatohepatitis (NASH)	2016/03/01	English	39
Lost microbes of COVID-19: Bifidobacterium, Faecalibacterium depletion and decreased microbiome diversity associated with SARS-CoV-2 infection severity	2022/04/01	English	38
Circulating miRNA in patients with non-alcoholic fatty liver disease and coronary artery disease	2016/07/01	English	37